facebook
TradedTraded
    Home
    Deals
    Newsletter
    Articles
    PropTech
    Partners


Messages

Go Pro
+ Submit+ Submit
All Deals
May 14, 2025 - Deals

DoorDash Acquires Deliveroo For $3.87 Billion And SevenRooms For $1.2 Billion

Property Image
DoorDash, led by CEO Tony Xu, announced two major acquisitions to expand its global footprint and diversify its offerings: it will acquire U.K.-based food delivery rival Deliveroo for £2.9 billion ($3.87B) and restaurant software platform SevenRooms for $1.2 billion in cash. The Deliveroo deal, expected to close in Q4 2025, gives DoorDash access to nine European markets and 50 million monthly users; Deliveroo was founded in 2013 by Will Shu. The SevenRooms acquisition, set to close in the second half of 2025, will enhance DoorDash’s B2B capabilities with CRM, reservations, and guest management tools used by clients like Marriott and MGM Resorts. DELIVEROO SALE PRICE: $3,860,000,000 SEVEN ROOMS SALE PRICE PRICE: $1,200,000,000 HQ: #SanFrancisco #California #VentureCapital #DoorDash #TonyXu #Deliveroo #SevenRooms #TradedVC

Property Image
Colossal Biosciences In Talks For Funding Round Targeting $23 Billion ValuationColossal Biosciences, the de-extinction biotech startup known for its efforts to recreate the woolly mammoth and other extinct species, is reportedly in talks to raise new funding at a valuation of roughly $23 billion–$24 billion, according to Axios. The potential raise would mark a significant jump for the five-year-old company, with investors valuing not only its genetic-engineering programs but also its broader genomics, reproductive technology, conservation, and intellectual property platform. Colossal has begun generating revenue through conservation technology sales and technology spinouts, including Astromech, an AI-driven predictive modeling company, and Form Bio, a computational biology platform, expanding its value beyond de-extinction efforts. FOUNDERS: Ben Lamm & George Church TARGET VALUATION: $23,000,000,000 HQ: Dallas, Texas #VentureCapital #ColossalBiosciences #BenLamm #GeorgeChurch #TradedVC